Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Fontana

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Arquivos Brasileiros De Cardiologia|November 28, 2012
True prevalence of resistant hypertensionAndréa Rodrigues Sabbatini, Vanessa Fontana, Heitor Moreno
Journal of the American Society of Hypertension : JASH|April 2, 2014
Relationship of left ventricular hypertrophy, age, and renal artery stenosisNatalia Ruggeri Barbaro, Vanessa Fontana, Heitor Moreno
International Journal of Hypertension|May 3, 2014
Angiotensinogen Variants among Resistant Hypertensive PatientsNatalia Ruggeri Barbaro, Vanessa Fontana, Heitor Moreno
Journal of Hypertension|December 16, 2014
An update on the role of adipokines in arterial stiffness and hypertensionAndréa R Sabbatini, Vanessa Fontana, Stephane Laurent, et al.
Frontiers in Microbiomes|March 19, 2026
The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapyJacob Dehinsilu, Chrysi Sergaki, Gregory Amos, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2014
Adipokines: novel players in resistant hypertensionAna Paula de Faria, Rodrigo Modolo, Vanessa Fontana, et al.
Mabs|January 6, 2021
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progressionMarco Stringhini, Jacqueline Mock, Vanessa Fontana, et al.
Arquivos Brasileiros De Cardiologia|June 4, 2015
Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertensionLeandro Lacerda, Ana Paula de Faria, Vanessa Fontana, et al.
British Journal of Clinical Pharmacology|October 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary preventionRichard M Turner, Vanessa Fontana, Richard FitzGerald, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 17, 2012
Circulating matrix metalloproteinases and their inhibitors in hypertensionVanessa Fontana, Pamela S Silva, Raquel F Gerlach, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Arquivos Brasileiros De Cardiologia|November 28, 2012
True prevalence of resistant hypertensionAndréa Rodrigues Sabbatini, Vanessa Fontana, Heitor Moreno
Journal of the American Society of Hypertension : JASH|April 2, 2014
Relationship of left ventricular hypertrophy, age, and renal artery stenosisNatalia Ruggeri Barbaro, Vanessa Fontana, Heitor Moreno
International Journal of Hypertension|May 3, 2014
Angiotensinogen Variants among Resistant Hypertensive PatientsNatalia Ruggeri Barbaro, Vanessa Fontana, Heitor Moreno
Journal of Hypertension|December 16, 2014
An update on the role of adipokines in arterial stiffness and hypertensionAndréa R Sabbatini, Vanessa Fontana, Stephane Laurent, et al.
Frontiers in Microbiomes|March 19, 2026
The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapyJacob Dehinsilu, Chrysi Sergaki, Gregory Amos, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2014
Adipokines: novel players in resistant hypertensionAna Paula de Faria, Rodrigo Modolo, Vanessa Fontana, et al.
Mabs|January 6, 2021
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progressionMarco Stringhini, Jacqueline Mock, Vanessa Fontana, et al.
Arquivos Brasileiros De Cardiologia|June 4, 2015
Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertensionLeandro Lacerda, Ana Paula de Faria, Vanessa Fontana, et al.
British Journal of Clinical Pharmacology|October 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary preventionRichard M Turner, Vanessa Fontana, Richard FitzGerald, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 17, 2012
Circulating matrix metalloproteinases and their inhibitors in hypertensionVanessa Fontana, Pamela S Silva, Raquel F Gerlach, et al.
Pageof 5